Skip to main content
. 2021 Aug 31;14:4659–4670. doi: 10.2147/OTT.S297523

Table 7.

Liver Function Indexes Before and After First DEB-TACE Therapy

Liver Function Indexes VL Patients (n=49) Non-VL Patients (n=237) P value
ALT (U/L), mean±SD
 Before DEB-TACE 47.4±41.2 49.7±29.1 0.711
 1 day after DEB-TACE 171.5±87.2 182.9±78.4 0.364
 7 days after DEB-TACE 75.2±33.6 71.4±39.9 0.534
 1 month after DEB-TACE 39.1±18.9 45.9±32.0 0.152
AST (U/L), mean±SD
 Before DEB-TACE 49.50±27.2 44.2±21.7 0.082
 1 day after DEB-TACE 163.6±56.5 161.7±67.2 0.832
 7 days after DEB-TACE 81.1±36.1 89.4±44.7 0.223
 1 month after DEB-TACE 57.4±35.1 54.1±38.7 0.581
ALB (g/L), mean±SD
 Before DEB-TACE 35.7±4.9 36.1±4.5 0.577
 1 day after DEB-TACE 31.9±5.5 30.9±5.0 0.212
 7 days after DEB-TACE 33.4±5.2 32.8±4.8 0.433
 1 month after DEB-TACE 37.5±5.0 37.9±4.5 0.579

Note: Comparison was determined by Student’s t test.

Abbreviations: DEB-TACE, drug-eluting beads transarterial chemoembolization; VL, vascular lake; ALT, alanine aspartate aminotransferase; SD, standard deviation; AST, aspartate aminotransferase; ALB, albumin.